Income Statement
CHINA PHARMA HOLDINGS, INC.
CPHI
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
4.53 | 7.01 | 8.10 | 9.64 | 10.87 | 10.92 | 12.33 | 13.21 | 15.57 | 20.35 | 24.93 | 32.81 | 54.51 | 81.17 |
|
Cost of Revenue
|
6.51 | 7.29 | 8.60 | 9.29 | 8.91 | 9.44 | 10.36 | 10.74 | 12.35 | 15.78 | 17.22 | 23.41 | 38.66 | 52.18 |
|
Gross Profit
|
-1.99 | -0.28 | -0.49 | 0.35 | 1.95 | 1.48 | 1.97 | 2.47 | 3.22 | 4.57 | 5.46 | -0.48 | 14.08 | 28.99 |
|
Operating Expenses
|
2.60 | 2.47 | 3.06 | 3.21 | 4.53 | 21.89 | 12.42 | 21.15 | 11.72 | 17.40 | 30.78 | 18.13 | 8.31 | 7.26 |
|
Research & Development
|
0.28 | 0.24 | 0.19 | 0.32 | 0.38 | 0.23 | 0.17 | 0.09 | 0.37 | - | 2.80 | 1.68 | - | - |
|
Selling, General & Administrative
|
1.78 | 1.47 | 1.89 | 1.65 | 1.82 | 2.29 | 1.95 | 2.02 | 2.27 | 1.90 | 1.72 | 2.40 | 3.31 | 3.72 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-4.59 | -2.75 | -3.55 | -2.86 | -2.58 | -20.41 | -10.45 | -18.68 | -8.50 | -12.83 | -25.32 | -18.61 | 5.76 | 21.72 |
|
Non-Operating Income
|
-0.15 | -0.33 | -0.42 | -0.54 | -0.29 | -0.29 | -0.41 | -0.47 | 0.38 | 2.51 | 0.65 | 0.34 | -0.30 | 21.04 |
|
Interest Income
|
0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.03 | 0.04 | 0.06 | 0.13 | 0.12 | 0.07 | 0.01 | 0.00 | 0.01 |
|
Interest Expense
|
0.05 | 0.33 | 0.43 | 0.54 | 0.29 | 0.32 | 0.45 | 0.54 | -0.85 | 1.17 | -0.79 | -0.35 | -0.31 | -0.26 |
|
Other Non-Op Income / Expense
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Income Before Tax
|
-4.74 | -3.08 | -3.97 | -3.40 | -2.87 | -20.70 | -10.86 | -19.15 | -8.87 | -15.35 | -25.97 | -18.95 | 5.60 | 0.69 |
|
Income Tax Expense
|
0.00 | 0.00 | 0.00 | 0.00 | - | 0.00 | -0.11 | 0.12 | 0.31 | 0.06 | 0.08 | 1.06 | 0.98 | -3.44 |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Net Income
|
-4.74 | -3.08 | -3.97 | -3.40 | 2.87 | -20.70 | -10.75 | 19.28 | -9.18 | -15.41 | -26.05 | -20.01 | 4.62 | 19.27 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-1.97 | 0.00 | -0.85 | 0.23 | 0.10 | -17.48 | -7.19 | -15.39 | -5.42 | -9.23 | -23.53 | -16.99 | 7.23 | 22.90 |
|
Earnings Per Share (Basic)
|
-0.27 | -0.91 | -0.76 | - | - | - | - | - | - | -0.35 | -0.60 | -0.46 | 0.11 | 0.44 |
|
Diluted EPS
|
-0.27 | - | - | - | - | - | - | - | - | -0.35 | -0.60 | -0.46 | 0.11 | 0.44 |
|
Weighted Average Shares
|
17.46 | 3.38 | 5.26 | - | - | - | - | - | - | 43.58 | - | - | - | - |
|
Diluted Weighted Avg Shares
|
- | - | - | - | - | - | - | - | - | 43.58 | - | - | 43.58 | - |
|
Comprehensive Income
|
-4.87 | -3.20 | -4.96 | -3.18 | -2.10 | -20.96 | -12.87 | - | - | - | - | - | 5.89 | 24.35 |